Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pathologica ; 113(4): 285-293, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34463673

RESUMO

Multiple myeloma accounts for 10-15% of all hematologic malignancies, and 20% of deaths related to cancers of the blood and bone marrow. Diagnosis is defined by the presence of a serum monoclonal spike (M-spike) of more than 3 g/dL or more than 10% clonal plasma cells in the bone marrow and at least one myeloma-defining event, such as hypercalcemia, anemia, bone lesions, or renal impairment. The kidney is a major target organ, and renal impairment is frequently the first manifestation of the disease. Renal damage occurs in up to 40% of patients and 10-20% will require dialysis. Monoclonal immunoglobulin light chains are the major causes of renal complications in multiple myeloma. Glomerular disease, with the deposition of monoclonal immunoglobulins or their components, includes monoclonal immunoglobulin deposition disease, AL or AH amyloidosis, type I cryoglobulinemia, proliferative glomerulonephritis with monoclonal IgG deposits, immunotactoid glomerulopathy, and fibrillary glomerulonephritis. In addition, tubulointerstitial diseases with the deposition of monoclonal immunoglobulins or their components, are constituted by light chain cast nephropathy, light chain proximal tubulopathy, and crystal-storing histiocytosis.We report the case of a 66-year-old woman who presented with albumin-predominant moderate proteinuria and renal failure. Serum and urine immunofixation electrophoresis showed monoclonal κ light chain in both. Renal biopsy confirmed κ-restricted crystal-storing renal disease involving proximal tubular epithelial cells and crystal storing histiocytosis. Multiple myeloma with crystal storing histiocytosis was discovered in bone marrow biopsy. Thus, we present an unusual case of a myeloma patient presenting light chain proximal tubulopathy and crystal-storing histiocytosis both in the kidney and in the bone marrow.


Assuntos
Histiocitose , Nefropatias , Mieloma Múltiplo , Paraproteinemias , Idoso , Feminino , Histiocitose/complicações , Humanos , Rim , Mieloma Múltiplo/complicações , Paraproteinemias/complicações
2.
G Ital Nefrol ; 38(1)2021 Feb 16.
Artigo em Italiano | MEDLINE | ID: mdl-33599424

RESUMO

Waldenström's disease is a rare haematological neoplasm involving B lymphocytes, characterized by medullary infiltrated lymphoplasmacytic lymphoma and by the presence of a monoclonal M paraprotein. Although rarely, this condition may lead to heterogeneous renal involvement and cause severe renal failure. We report the clinical case of a patient with overt nephrotic syndrome in Waldenström's disease treated with a combination chemotherapy (rituximab, cyclophosphamide, dexamethasone) until complete renal and haematological remission.


Assuntos
Síndrome Nefrótica , Macroglobulinemia de Waldenstrom , Ciclofosfamida , Humanos , Rim , Síndrome Nefrótica/tratamento farmacológico , Síndrome Nefrótica/etiologia , Rituximab , Macroglobulinemia de Waldenstrom/complicações , Macroglobulinemia de Waldenstrom/tratamento farmacológico
3.
Ann Ital Med Int ; 18(1): 51-5, 2003.
Artigo em Italiano | MEDLINE | ID: mdl-12739430

RESUMO

The present case report refers to a multiorgan autoimmune disease manifesting following thymectomy performed for a benign thymoma. This disease is characterized by hypothyroidism, severe myasthenia, polymyositis and alopecia which are organ-specific diseases probably with a different time of onset but which are all an expression of the same immunopathologic process occurring in individuals who have a genetic predisposition. Characteristic of the present case is not only the association of the different immunopathologic clinical pictures but also the rather difficult differential diagnosis between a hypothyroidism-related myopathy and polymyositis. It was possible to formulate the diagnosis by integrating the results of clinical and laboratory evaluation with the therapeutic outcome. The onset of the syndrome was attributed to the withdrawal, following surgery, of the inhibitory effects of the thymoma on some clones of autoreactive lymphocytes.


Assuntos
Doenças Autoimunes/sangue , Doenças Autoimunes/diagnóstico , Alopecia/sangue , Alopecia/diagnóstico , Doenças Autoimunes/enzimologia , Doenças Autoimunes/imunologia , Creatina Quinase/sangue , Feminino , Antígeno HLA-DR3/sangue , Humanos , Hipotireoidismo/sangue , Hipotireoidismo/diagnóstico , Pessoa de Meia-Idade , Miastenia Gravis/sangue , Miastenia Gravis/diagnóstico , Polimiosite/sangue , Polimiosite/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA